Post-traumatic stress disorder was associated with 4.2% to 9.3% higher annual per-patient healthcare costs compared with MDD among patients covered by Medicaid or private insurance.
This population-based analysis of patients with cancer in California found significant differences in proton beam therapy use by health insurance type, race/ethnicity, and socioeconomic status.
Oral anticancer medications are frequently used to treat patients with cancer. We found significant time and energy burdens for clinic staff and patients in obtaining these drugs.
This article provides insight on the work of 7 of Project ECHO’s replicating partners from around the world who are implementing the ECHO model to address the knowledge gap that underlies integrated palliative care crisis.
Telephone care management increased mental health service use for Medicaid beneficiaries with depression but did not reduce depression severity. More intensive services may be needed.
Decreasing statin copayments because of the patent expiration of simvastatin has led to moderate increases in therapy adherence.
The authors interviewed patients with access to a price transparency website. Despite a positive opinion of price shopping in theory, respondents reported barriers to doing so in reality.
Prescription cost and pharmacy convenience were identified as the most significant drivers of out-of-plan pharmacy use.
For 2 successive years, the Hackensack Alliance Accountable Care Organization achieved cost savings and maintained quality by using physicians with patient-centered medical homes and nurse care coordinators focused on high-risk patients.
Between 2005 and 2011, rates of cardiac catheterization laboratory false activation doubled while mean door-to-balloon times for primary PCI declined.
Out-of-pocket costs required by Medicare prescription drug plans for drugs available through Walmart’s generic drug discount program have decreased from 2009 to 2017.
Medication adherence in hyperlipidemia remains poor on a nationally representative level. Predictors of medication adherence from a nationally representative commercial health plan are reported.
Authors from My Gene Counsel discuss gaps in CMS reimbursement policy for genetic testing and counseling, in light of advances in guidelines from groups that include the National Comprehensive Cancer Network.
This article describes perspectives of Medicare Advantage (MA) insurers about participating in the CMS value-based insurance design model test launched in 2017.
This is the first empirical evidence to demonstrate increased competition and innovation in the EHR industry as a result of the HITECH program.
Hospital CEO and former SNF administrator, Dr Josh Luke, who founded the National Readmission Prevention Collaborative, discusses MEDPAC's recommendation to CMS that anti-steering regulations for hospitals be done away with.